Ning Sun
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Peptidase Inhibition and Analysis
Papers in
-
- Ubiquitin and proteasome pathways 10
- Protein Degradation and Inhibitors 9
- Epigenetics and DNA Methylation 6
- RNA modifications and cancer 6
- Surgery 13
- Pancreatic function and diabetes 5
- Co-authors
- Biao Jiang (6 shared papers)Xiaobao Yang (6 shared papers)Chengshuo Zhang (16 shared papers)Jialin Zhang (12 shared papers)Xing Qiu (4 shared papers)Ao Jiao (9 shared papers)Jifeng Feng (5 shared papers)Xiaoling Song (4 shared papers)
- Journals
- Journal of Medicinal Chemistry (3 papers)European Journal of Medicinal Chemistry (3 papers)Cancer Science (3 papers)Nucleic Acids Research (3 papers)Scientific Reports (3 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Ning Sun
71 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 98
- Hematology 179
- Oncology 359
- Molecular Biology 917
- Cancer Research 164
- Pharmacology 109
Countries citing papers authored by Ning Sun
This map shows the geographic impact of Ning Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Sun more than expected).
Fields of papers citing papers by Ning Sun
This network shows the impact of papers produced by Ning Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Sun. The network helps show where Ning Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Ning Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 108 | |
| 2 | 2017 | 103 | |
| 3 | 2009 | 90 | |
| 4 | 2021 | 87 | |
| 5 | 2015 | 67 | |
| 6 | 2020 | 66 | |
| 7 | 2019 | 65 | |
| 8 | 2010 | 48 | |
| 9 | 2023 | 41 | |
| 10 | 2021 | 38 | |
| 11 | 2020 | 35 | |
| 12 | 2009 | 34 | |
| 13 | 2018 | 32 | |
| 14 | 2021 | 32 | |
| 15 | 2017 | 30 | |
| 16 | 2022 | 27 | |
| 17 | 2018 | 27 | |
| 18 | 2015 | 26 | |
| 19 | 2016 | 25 | |
| 20 | 2009 | 25 |
About Ning Sun
Ning Sun is a scholar working on Molecular Biology, Surgery, Oncology, Pharmacology and Cancer Research, having authored 81 papers that have together received 1.6k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (10 papers), Protein Degradation and Inhibitors (9 papers), Microbial Natural Products and Biosynthesis (7 papers), Epigenetics and DNA Methylation (6 papers), RNA modifications and cancer (6 papers), Multiple Myeloma Research and Treatments (5 papers), Pancreatic function and diabetes (5 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Hematology (179 citations), Oncology (359 citations), Molecular Biology (917 citations), Cancer Research (164 citations) and Pharmacology (109 citations). Ning Sun has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Biao Jiang, Xiaobao Yang, Chengshuo Zhang, Jialin Zhang, Xing Qiu, Ao Jiao, Jifeng Feng, Xiaoling Song, Hui Zhong and Lü Cheng. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Cancer Science, Nucleic Acids Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.